JOURNAL OF COMPARATIVE PATHOLOGY, published by Elsevier Science Ltd, stands as a significant publication within the fields of pathology and forensic medicine, as well as veterinary studies. With an ISSN of 0021-9975 and an E-ISSN of 1532-3129, this journal has been disseminating critical research since 1950, contributing to the advancement of knowledge through its focus on comparative pathology. The journal's reputable standing is underscored by its Q3 classification in Pathology and Forensic Medicine and Q2 in Veterinary (miscellaneous) for 2023, reflecting its vital role in shaping contemporary discourse in these domains. The Scopus ranks further solidify its presence, placing it at the 51st percentile in general veterinary sciences and the 32nd percentile in pathology—a testament to the quality and relevance of the contributions it publishes. Although it operates under a subscription model, the journal remains accessible to researchers and practitioners who aim to deepen their understanding of pathological phenomena across species, enhance diagnostic accuracy, and improve clinical practices. With a steadfast commitment to rigorous peer review and a global readership, the JOURNAL OF COMPARATIVE PATHOLOGY is an essential resource for those engaged in research and professional practice, fostering collaborations and innovations that bridge complementary areas of study.

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

JOURNAL OF CUTANEOUS PATHOLOGY, published by WILEY, serves as a vital resource in the fields of dermatology, pathology, and histology, reflecting its distinguished position with impressive categorization quartiles: Q2 in Dermatology and Pathology and Forensic Medicine, and Q3 in Histology for 2023. Established in 1974, this esteemed journal features peer-reviewed research that drives advancements in understanding skin diseases, with a convergence period extending to 2024. The journal's impactful contributions are evident through its Scopus rankings, placing it among the top tiers of its category, specifically holding the 52nd rank in Dermatology. Researchers, professionals, and students will find the journal invaluable for its rich content and critical insights into cutaneous pathology, despite its current non-open access status. The journal's dedication to fostering knowledge in this specialized field underlines its significance as a go-to reference for ongoing scholarship and clinical practice.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.

Indian Journal of Paediatric Dermatology (ISSN: 2319-7250; E-ISSN: 2319-7269), published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the specialized field of paediatric dermatology. As a peer-reviewed open access journal since 2013, it aims to disseminate cutting-edge research, clinical practices, and innovative developments that cater to the specific dermatological needs of children. The journal provides an essential forum for collaboration among researchers, clinicians, and students, facilitating the sharing of knowledge on a wide array of topics, including skin conditions unique to paediatric populations, treatment methodologies, and advancements in dermatological care. With a commitment to enhancing the understanding and treatment of paediatric skin diseases, this journal plays a critical role in shaping best practices and informing future research directions in a rapidly evolving field.

The Journal of Clinical and Experimental Hematopathology, published by the Japanese Society of Lymphoreticular Tissue Research, is a vital resource dedicated to advancing the field of hematopathology. With an impressive Open Access model since 2019, this journal provides researchers, clinicians, and students from around the world with unfettered access to cutting-edge research and developments in hematology and pathophysiology. Based in Japan, it has established a prominent reputation in the academic community, boasting a Q3 quartile ranking in Hematology and Q1 rankings in both Medicine (Miscellaneous) and Pathophysiology as of 2023. With its innovative contributions and high visibility, the journal not only fosters scholarly discourse but also impacts clinical practices, making it an essential publication for anyone interested in the complexities of hematologic disorders. For submissions and further inquiries, the journal is located at Nagoya University Graduate School of Medicine, Japan.

Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.